RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ocumension Therapeutics Stock

Ocumension Therapeutics ROA 2024

Ocumension Therapeutics ROA

-0.12

Ticker

1477.HK

ISIN

KYG674111011

WKN

A2P723

In 2024, Ocumension Therapeutics's return on assets (ROA) was -0.12, a -12.23% increase from the -0.13 ROA in the previous year.

Ocumension Therapeutics Aktienanalyse

What does Ocumension Therapeutics do?

Ocumension Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Ocumension Therapeutics's Return on Assets (ROA)

Ocumension Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Ocumension Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Ocumension Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Ocumension Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Ocumension Therapeutics stock

What is the Return on Assets (ROA) of Ocumension Therapeutics this year?

The Return on Assets (ROA) of Ocumension Therapeutics is -0.12 undefined this year.

What was the ROA of Ocumension Therapeutics compared to the previous year?

The ROA of Ocumension Therapeutics has increased by -12.23% compared to the previous year.

What consequences do high ROA have for investors of Ocumension Therapeutics?

A high ROA is advantageous for investors of Ocumension Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Ocumension Therapeutics?

A low ROA can be unfavorable for investors of Ocumension Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Ocumension Therapeutics affect the company?

An increase in ROA of Ocumension Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Ocumension Therapeutics impact the company?

A reduction in the ROA of Ocumension Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Ocumension Therapeutics?

Some factors that can influence the ROA of Ocumension Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Ocumension Therapeutics important for investors?

The ROA of Ocumension Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Ocumension Therapeutics take to improve ROA?

To improve ROA, Ocumension Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Ocumension Therapeutics pay?

Over the past 12 months, Ocumension Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ocumension Therapeutics is expected to pay a dividend of 0 CNY.

What is the dividend yield of Ocumension Therapeutics?

The current dividend yield of Ocumension Therapeutics is .

When does Ocumension Therapeutics pay dividends?

Ocumension Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ocumension Therapeutics?

Ocumension Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Ocumension Therapeutics?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ocumension Therapeutics located?

Ocumension Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ocumension Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ocumension Therapeutics from 9/13/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Ocumension Therapeutics pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Ocumension Therapeutics in the year 2023?

In the year 2023, Ocumension Therapeutics distributed 0 CNY as dividends.

In which currency does Ocumension Therapeutics pay out the dividend?

The dividends of Ocumension Therapeutics are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ocumension Therapeutics

Our stock analysis for Ocumension Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ocumension Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.